Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.390 enrolled

Overview

The purpose of the study is to compare pregabalin to Venlafaxine XR and placebo in the treatment of generalized anxiety disorder.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

390

Conditions

Anxiety

Interventions

PregabalinDRUG

Venlafaxine XRDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male and female outpatients with diagnosis of generalized anxiety disorder. Exclusion Criteria: * Any serious or uncontrolled medical condition. * Current diagnosis of depression, dysthymia, obsessive-compulsive disorder.

Locations (45)

Outcomes

Primary Outcomes

Evaluation of the efficacy of pregabalin and Venlafaxine XR in the treatment of generalized anxiety disorder.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Pfizer Investigational Site

De Pinte, Belgium

Pfizer Investigational Site

Ghent, Belgium

Pfizer Investigational Site

Waregem, Belgium

Pfizer Investigational Site

Kelowna, British Columbia, Canada

Pfizer Investigational Site

Hamilton, Ontario, Canada

Pfizer Investigational Site

Ottawa, Ontario, Canada

Pfizer Investigational Site

Gatineau, Quebec, Canada

Pfizer Investigational Site

Saint-Jean-sur-Richelieu, Quebec, Canada

Pfizer Investigational Site

Angoulême, France

Pfizer Investigational Site

Arcachon, France

...and 35 more locations